Brain Diseases
172
45
49
67
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
19 trials with published results (11%)
Research Maturity
67 completed trials (39% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.8%
10 terminated out of 172 trials
87.0%
+0.5% vs benchmark
6%
11 trials in Phase 3/4
28%
19 of 67 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 67 completed trials
Clinical Trials (172)
Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Stroke Cerebral Reorganization Pathways (SPECTRE)
Brain Tissue Specimen Collection
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific
Pilot Study for PET/MR Imaging of Covid-19
Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
Selective Activation of the Adrenomedullin Receptors in Migraine
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Safety and Efficacy of SINOMED SR for Endovascular Treatment of Acute Ischemic Stroke
Impact of COVID-19 Vaccines on Cerebrovascular Health
CUHK Brain Health Longitudinal Study
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Evaluation of a New MRI Technique to Reduce Breathing-Related Artifacts in Brain Imaging
Rapamycin-Eluting Vertebral Stents In The Real-World Treatment of Symptomatic Intracranial Atherosclerotic Stenosis
Cerebral Arteriovenous Malformation With Aneurysm: Epidemiology, Clinical Features, and Prognosis
Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
Amylin-Induced Migraine Attacks Without Aura